Different mutational characteristics of the subsets of EGFR-tyrosine kinase inhibitor sensitizing mutation-positive lung adenocarcinoma

Table 2 Classification of variants in study cohort according to the VEP

Type of variants	Number of mutations
Missense	346
Benign mutations	127
Modifying	0
Nonsense	6
Frameshift	13
Splicing site	1
Inframe insertion and deletion	37
Nonstop mutation	0
Total	530

ISSN: 1471-2407